18F-氟代脱氧葡萄糖PET-CT在头颈部肿瘤中的应用价值

吴湖炳

downloadPDF
文章导航 > 国际放射医学核医学杂志  > 2005,  29 > 5: (205-209)  
引用本文:
shu
Citation:
shu

18F-氟代脱氧葡萄糖PET-CT在头颈部肿瘤中的应用价值

  • 510515 广州, 第一军医大学附属南方医院PET中心

  • 中图分类号: R814.42;R817.4

The clinical application value of 18F-FDG PET-CT on the head and neck cancer

  • PET Center, Nanfang Hospital, The Nanfang Medicial University, Guangzhou 510515, China

  • CLC number: R814.42;R817.4

  • 摘要: PET-CT能对恶性肿瘤病灶进行准确定位,在头颈部肿瘤的诊断、定位及指导临床治疗方面与单纯PET相比具有明显的优势。PET和CT优势互补,有助于进一步提高诊断及分期的准确性和可信度,有助于鉴别正常生理性摄取、炎症和恶性肿瘤,同时可以更好地指导临床精确放疗。18F-氟代脱氧葡萄糖(18F-FDG) PET-CT在大多数头颈部恶性肿瘤的诊断方面虽然有明显的优越性,但在甲状腺和腮腺病灶的良恶性鉴别、急性炎症与肿瘤的鉴别等方面仍有不足。
    Abstract: PET-CT is a good modality for localization of the malignant lesions. It is superior to PET in the diagnosis, localization and guiding treatment for head and neck cancer. Possessing of the superiority of PET and CT, PET-CT can improves the accuracy and confidence for diagnosis and staging and helps to reliably distinguish malignant lesions from physiologic uptake and some inflammation. It is also helpful for guiding more accurate radiotherapy. Although PET-CT has a lot of superiorities, it still has some shortcomings in the diagnosis of the thyroid cancer, parotid gland tumor and in the discriminating malignancy from some active inflammation.
  • [1] 谷铣之.现代肿瘤学(临床部分)[M].北京:北京医科大学中国协和医科大学联合出版社,1993.185-321.
    [2] 吴湖炳,王全师,王明芳,等.PET/CT诊断恶性肿瘤及其转移灶的价值[J].中华核医学杂志,2005,25(2):84-86.
    [3] Syed R, Bomanji JB, Nagabhushan N, et al. Impact of combined (18)F-FDG PET/CT in head and neck tumours[J]. Br J Cancer, 2005, 92(6):1046-1050.
    [4] 丁其勇,管一晖,赵军,等.PET/CT与PET在病变定位诊断中的对照研究[J].中华核医学杂志,2005,25(2):81-83.
    [5] Yeung HW, Schöder H, Smith A, et al. Clinical value of combined positron emission tomography/computed tomography imaging in the Interpretation of 2-Deoxy-2-[F-18] fluoro-d-glucose-positron emission tomography studies in cancer patients[J]. Mol Imaging Biol, 2005,7(3):229-235.
    [6] Branstetter BF, Blodgett TM, Zimmer LA, et al. Head and neck malignancy:is PET/CT more accurate than PET or CT alone?[J]. Radiology,2005,235(2):580-586.
    [7] Zimmer LA, Snyderman C, Fukui MB, et al. The use of combined PET/CT for localizing recurrent head and neck cancer:the Pittsburgh experience[J]. Ear Nose Throat J, 2005, 84(2):108-110.
    [8] Goerres GW, von Schulthess GK, Steinert HC, et al. Why most PET of lung and head-and-neck cancer will be PET/CT[J]. J Nucl Med,2004,45(Suppl 1):66S-71S.
    [9] Goerres GW, Von Schulthess GK, Hany TF, et al. Positron emission tomography and PET/CT of the head and neck:FDG uptake in normal anatomy, in benign lesions, and in changes resulting from treatment[J]. Am J Roentgenol, 2002,179(5):1337-1343.
    [10] Yen TC, Chang JT, Ng SH, et al. The value of 18F-FDG PET in the detection of stage MO carcinoma of the nasopharynx[J]. J Nucl Med,2005,46(3):405-410.
    [11] Solberg TD, Agazaryan N, Goss BW, et al. A feasibility study of 18F-fluorodeoxyglucose positron emission tomography targeting and simultaneous integrated boost for intensit-modulated radiosurgery and radiotherapy[J]. J Neurosurg, 2004,101(Suppl 3):381-389.
    [12] Ciernik IF, Dizendorf E, Banmert BG, et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT):a feasibility study[J]. Int J Radiat Oncol Biol Phys,2003,57(3):853-863.
    [13] Koshy M, Paulino AC, Howell R, et al. F-18 FDG PET-CT fusion in radiotherapy treatment planning for head and neck cancer[J]. Head Neck, 2005, 27(6):494-502.
    [14] Schöder H, Yeung HW, Gonen M, et al. Head and neck cancer:clinical usefulness and accuracy of PET/CT image fusion[J]. Radiology, 2004, 231(1):65-72.
    [15] Nahas Z, Goldenberg D, Fakhry C, et al. The role of positron emission tomography/computed tomography in the management of recurrent papillary thyroid carcinoma[J]. Laryngoscope, 2005, 115(2):237-243.
    [16] Freudenberg LS, Antoch G, Jentzen W, et al. Value of (124)I-PET/CT in staging of patients with differentiated thyroid[J]. Eur Radiol,2004, 14(11):2092-2098.
    [17] Van Westreenen HL, Cobben DC, Jager PL, et al. Comparison of 18F-FLT PET and 18F-FDG PET in esophageal cancer[J]. J Nucl Med, 2005,46(3):400-404.
  • [1] 刘建军 , 黄钢 . 18F-氟代脱氧葡萄糖PET和PET-CT在转移性骨肿瘤中的应用研究. 国际放射医学核医学杂志, 2005, 29(5): 213-216.
    [2] 季仲友 . PET-CT中诊断性CT的必要性与临床应用. 国际放射医学核医学杂志, 2005, 29(5): 197-200.
    [3] 华逢春 , 管一晖 , 赵军 . 18F-氟代脱氧葡萄糖PET及PET-CT在淋巴瘤中的临床应用. 国际放射医学核医学杂志, 2005, 29(5): 216-219,226.
    [4] 蔡莉 , 李彦生 . 氟代脱氧葡萄糖与氨基酸PET在脑肿瘤中的对比研究. 国际放射医学核医学杂志, 2005, 29(1): 10-14.
    [5] 袁志斌 . 正电子肿瘤阳性显像剂18F-AMT. 国际放射医学核医学杂志, 2002, 26(5): 193-195.
    [6] 田蓉蓉 , 薄云峰 , 张毅勋 , 原凌 , 赵铭 , 张红雨 . 18F-FDG PET/CT显像与结直肠癌治疗前分期的相关性研究. 国际放射医学核医学杂志, 2018, 42(1): 9-14. doi: 10.3760/cma.j.issn.1673-4114.2018.01.002
    [7] 尹立杰 . 双时相18F-FDG PET在肿瘤良恶性鉴别诊断中的应用. 国际放射医学核医学杂志, 2004, 28(2): 53-56.
    [8] 董孟杰 , 林祥通 , 赵军 . PET-CT在卵巢癌中的临床应用价值. 国际放射医学核医学杂志, 2005, 29(5): 209-213.
    [9] 陈香 , 赵军 , 管一晖 . PET-CT常见伪影. 国际放射医学核医学杂志, 2005, 29(5): 201-205.
    [10] 张锦明 , 田嘉禾 . 11C标记的放射性药物在PET-CT肿瘤诊断上的应用. 国际放射医学核医学杂志, 2005, 29(5): 232-237.
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  1168
  • HTML全文浏览量:  160
  • PDF下载量:  2
出版历程
  • 收稿日期:  2005-06-24

18F-氟代脱氧葡萄糖PET-CT在头颈部肿瘤中的应用价值

  • 510515 广州, 第一军医大学附属南方医院PET中心
  • 收稿日期: 2005-06-24

摘要: PET-CT能对恶性肿瘤病灶进行准确定位,在头颈部肿瘤的诊断、定位及指导临床治疗方面与单纯PET相比具有明显的优势。PET和CT优势互补,有助于进一步提高诊断及分期的准确性和可信度,有助于鉴别正常生理性摄取、炎症和恶性肿瘤,同时可以更好地指导临床精确放疗。18F-氟代脱氧葡萄糖(18F-FDG) PET-CT在大多数头颈部恶性肿瘤的诊断方面虽然有明显的优越性,但在甲状腺和腮腺病灶的良恶性鉴别、急性炎症与肿瘤的鉴别等方面仍有不足。

English Abstract

    全文HTML

参考文献 (17)

目录

    /

    返回文章
    返回

    版权所有©中华医学会   备案号：津ICP备15006720号-3

    地址：天津市南开区白堤路238号电话：86-22-58089989
    86-22-85682389    传真：022-87890607

    本系统由 北京仁和汇智信息技术有限公司 开发 技术支持： info@rhhz.net